Ticker Scorecard - KROS Basics Company: Keros Therapeutics, Inc. IPO Date: April 8, 2020 Sector: Healthcare Industry: Biotech Market Cap: $446.39M Activated in VL: True Average Daily Range Avg Daily Range: $1.28 | 2.78% Avg Daily Range (30 D): $0.26 | 2.21% Avg Daily Range (90 D): $0.86 | 2.32% Institutional Daily Volume Avg Daily Volume: .23M Avg Daily Volume (30 D): 1.56M Avg Daily Volume (90 D): 1.04M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 89 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 1,735 Avg Inst. Trade: $1.92M Avg Inst. Trade (30 D): $1.37M Avg Inst. Trade (90 D): $1.79M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.01M Avg Closing Trade (30 D): $1.65M Avg Closing Trade (90 D): $2.3M Avg Closing Volume: 46.78K     News Jun 25, 2024 @ 6:43 PM Analyst Sees Keros Therapeutics As Next Acceleron,... Source: Vandana Singh Jun 17, 2024 @ 8:01 PM Keros Therapeutics Announces Leadership Updates Source: Keros Therapeutics, Inc. Jun 17, 2024 @ 10:00 AM Keros Therapeutics Presents Clinical Data from its... Source: Keros Therapeutics, Inc. Jun 16, 2024 @ 11:05 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast May 28, 2024 @ 8:01 PM Keros Therapeutics Appoints Jean-Jacques BienaimÃ... Source: Keros Therapeutics, Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-1.41 $-1.25 $-1.21 Diluted EPS $-1.41 $-1.25 $-1.21 Revenue $ .39M $ .04M $ .08M Gross Profit $ $ $ Net Income / Loss $ -52.96M $ -45.26M $ -43.11M Operating Income / Loss $ -58.66M $ -50.44M $ -48.48M Cost of Revenue $ $ $ Net Cash Flow $ 125.06M $ -36.58M $ 111.3M PE Ratio